Trials / Sponsors / Chengdu New Radiomedicine Technology Co. LTD.
Chengdu New Radiomedicine Technology Co. LTD.
Industry · 4 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Safety Trial of 68Ga/177Lu-NRT6020 in FAP-Positive Advanced Solid Tumor Patients Solid Tumor Malignancy | Phase 1 | 2025-11-29 |
| Recruiting | Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere Unresectable Hepatocellular Carcinoma | Phase 3 | 2025-04-15 |
| Recruiting | Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) Unresectable Pancreatic Cancer | Phase 1 | 2024-01-09 |
| Completed | Safety and Efficacy of TareSphere in Patients With Unresectable Hepatocellular Carcinoma Unresectable Hepatocellular Carcinoma | Phase 1 | 2023-08-08 |